Morgan Stanley Adjusts MICROPORT Target Price to HK$10.5, Keeps 'In-Line' Stance

Stock News05-21

Morgan Stanley has released a research report following a meeting with the management of MICROPORT during a healthcare industry survey in Shanghai. Key discussion points included regulatory updates, robust overseas business momentum, and balance sheet management. The firm maintains its 'In-Line' rating on MICROPORT. Due to slowing liquidity and subdued sector sentiment, the holding company discount has been increased from 30% to 45%, leading to a reduction in the target price from HK$16 to HK$10.5. The bank believes that more definitive evidence confirming an organic, gross margin-driven path to breakeven is needed for a more sustainable valuation re-rating. Management guidance indicates low single-digit growth for the first half of 2026, primarily influenced mildly by inventory clearance and sales representative policies, while reiterating the full-year 2026 target of high single-digit growth. Recent conflicts in the Middle East have disrupted overseas deliveries of MICROPORT's interventional and orthopedic products. Momentum in the surgical robotics business remains positive, with second-quarter growth accelerating compared to the first quarter, primarily driven by overseas markets, while domestic tender conditions are also expected to improve.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1149265840?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-21 17:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1149265840","market":"sh","top_or_hot":-1,"title":"Morgan Stanley Adjusts MICROPORT Target Price to HK$10.5, Keeps 'In-Line' Stance","media":"Stock News","content":"<p>Morgan Stanley has released a research report following a meeting with the management of MICROPORT during a healthcare industry survey in Shanghai. Key discussion points included regulatory updates, robust overseas business momentum, and balance sheet management. The firm maintains its 'In-Line' rating on MICROPORT. Due to slowing liquidity and subdued sector sentiment, the holding company discount has been increased from 30% to 45%, leading to a reduction in the target price from HK$16 to HK$10.5. The bank believes that more definitive evidence confirming an organic, gross margin-driven path to breakeven is needed for a more sustainable valuation re-rating. Management guidance indicates low single-digit growth for the first half of 2026, primarily influenced mildly by inventory clearance and sales representative policies, while reiterating the full-year 2026 target of high single-digit growth. Recent conflicts in the Middle East have disrupted overseas deliveries of MICROPORT's interventional and orthopedic products. Momentum in the surgical robotics business remains positive, with second-quarter growth accelerating compared to the first quarter, primarily driven by overseas markets, while domestic tender conditions are also expected to improve.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Morgan Stanley Adjusts MICROPORT Target Price to HK$10.5, Keeps 'In-Line' Stance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMorgan Stanley Adjusts MICROPORT Target Price to HK$10.5, Keeps 'In-Line' Stance\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-05-21 17:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Morgan Stanley has released a research report following a meeting with the management of MICROPORT during a healthcare industry survey in Shanghai. Key discussion points included regulatory updates, robust overseas business momentum, and balance sheet management. The firm maintains its 'In-Line' rating on MICROPORT. Due to slowing liquidity and subdued sector sentiment, the holding company discount has been increased from 30% to 45%, leading to a reduction in the target price from HK$16 to HK$10.5. The bank believes that more definitive evidence confirming an organic, gross margin-driven path to breakeven is needed for a more sustainable valuation re-rating. Management guidance indicates low single-digit growth for the first half of 2026, primarily influenced mildly by inventory clearance and sales representative policies, while reiterating the full-year 2026 target of high single-digit growth. Recent conflicts in the Middle East have disrupted overseas deliveries of MICROPORT's interventional and orthopedic products. Momentum in the surgical robotics business remains positive, with second-quarter growth accelerating compared to the first quarter, primarily driven by overseas markets, while domestic tender conditions are also expected to improve.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"EWH","symbol_name":"香港ETF-iShares MSCI","start_time":0,"source_url":"","article_id":"1149265840","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1149265840","pubTimestamp":1779354023,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Morgan Stanley has released a research report following a meeting with the management of MICROPORT during a healthcare industry survey in Shanghai. Key discussion points included regulatory updates,...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"EWH":"香港ETF-iShares MSCI","BK1100":"医疗保健设备","BK1589":"北水核心资产","00853":"微创医疗","BK1585":"昨日强势股","BK1583":"高瓴概念"},"translate_title":"大摩将微创目标价调整至10.5港元，维持“一致”立场","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"EWH":1,"00853":1},"content_text":"Morgan Stanley has released a research report following a meeting with the management of MICROPORT during a healthcare industry survey in Shanghai. Key discussion points included regulatory updates, robust overseas business momentum, and balance sheet management. The firm maintains its 'In-Line' rating on MICROPORT. Due to slowing liquidity and subdued sector sentiment, the holding company discount has been increased from 30% to 45%, leading to a reduction in the target price from HK$16 to HK$10.5. The bank believes that more definitive evidence confirming an organic, gross margin-driven path to breakeven is needed for a more sustainable valuation re-rating. Management guidance indicates low single-digit growth for the first half of 2026, primarily influenced mildly by inventory clearance and sales representative policies, while reiterating the full-year 2026 target of high single-digit growth. Recent conflicts in the Middle East have disrupted overseas deliveries of MICROPORT's interventional and orthopedic products. Momentum in the surgical robotics business remains positive, with second-quarter growth accelerating compared to the first quarter, primarily driven by overseas markets, while domestic tender conditions are also expected to improve.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"express","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1149265840","isCrawlerRequest":true}